Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs Illinois Tool Works Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Illinois Tool Works Inc. trades at $265.27 (market cap $77.99B). The key difference: Illinois Tool Works Inc. is far larger — about 23.4× Adaptive Biotechnologies Corp's market cap, and Illinois Tool Works Inc. pays a 2.38% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | ITW | |
|---|---|---|
Market Cap | $3.33B | $77.99B |
Sector | Health | Industrials |
52-Week High | $22.37 | $299.60 |
52-Week Low | $10.24 | $241.07 |
Enterprise Value | $3.19B | $86.31B |
Dividend Yield | — | 2.38% |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →